PMC:7253233 / 2103-2647
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
99 | 43-51 | Species | denotes | patients | Tax:9606 |
100 | 267-275 | Species | denotes | Patients | Tax:9606 |
101 | 18-26 | Disease | denotes | seizures | MESH:D012640 |
102 | 57-65 | Disease | denotes | COVID-19 | MESH:C000657245 |
103 | 81-89 | Disease | denotes | seizures | MESH:D012640 |
104 | 137-156 | Disease | denotes | cortical irritation | MESH:D001523 |
105 | 250-265 | Disease | denotes | viral infection | MESH:D001102 |
106 | 299-307 | Disease | denotes | seizures | MESH:D012640 |
107 | 333-347 | Disease | denotes | encephalopathy | MESH:D001927 |
108 | 419-428 | Disease | denotes | epileptic | MESH:D004827 |
109 | 490-498 | Disease | denotes | seizures | MESH:D012640 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T9 | 164-169 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
T10 | 170-175 | Body_part | denotes | brain | http://purl.org/sig/ont/fma/fma50801 |
T11 | 215-223 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T10 | 164-183 | Body_part | denotes | blood–brain barrier | http://purl.obolibrary.org/obo/UBERON_0000120 |
T11 | 164-169 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
T12 | 170-175 | Body_part | denotes | brain | http://purl.obolibrary.org/obo/UBERON_0000955 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T22 | 57-65 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T23 | 250-265 | Disease | denotes | viral infection | http://purl.obolibrary.org/obo/MONDO_0005108 |
T24 | 256-265 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T25 | 333-347 | Disease | denotes | encephalopathy | http://purl.obolibrary.org/obo/MONDO_0005560 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T22 | 164-169 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T23 | 164-169 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
T24 | 170-175 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | brain |
T25 | 170-175 | http://www.ebi.ac.uk/efo/EFO_0000302 | denotes | brain |
T26 | 236-237 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 184-193 | http://purl.obolibrary.org/obo/GO_0009056 | denotes | breakdown |
T3 | 250-265 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infection |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T15 | 6-26 | Phenotype | denotes | symptomatic seizures | http://purl.obolibrary.org/obo/HP_0011145 |
T16 | 81-89 | Phenotype | denotes | seizures | http://purl.obolibrary.org/obo/HP_0001250 |
T17 | 299-307 | Phenotype | denotes | seizures | http://purl.obolibrary.org/obo/HP_0001250 |
T18 | 333-347 | Phenotype | denotes | encephalopathy | http://purl.obolibrary.org/obo/HP_0001298 |
T19 | 490-498 | Phenotype | denotes | seizures | http://purl.obolibrary.org/obo/HP_0001250 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T22 | 0-74 | Sentence | denotes | Acute symptomatic seizures are possible in patients with COVID-19 disease. |
T23 | 75-266 | Sentence | denotes | These seizures are likely multifactorial in origin, including cortical irritation due to blood–brain barrier breakdown, precipitated by the cytokine reaction as a part of the viral infection. |
T24 | 267-437 | Sentence | denotes | Patients with clinical signs of seizures or otherwise unexplained encephalopathy may benefit from electroencephalography monitoring and/or empiric anti-epileptic therapy. |
T25 | 438-544 | Sentence | denotes | Further studies are needed to elucidate the risk of seizures and benefit of monitoring in this population. |